Doximity, Inc. (NASDAQ:DOCS) Shares Bought by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. raised its position in Doximity, Inc. (NASDAQ:DOCS) by 13.1% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 19,075 shares of the company’s stock after buying an additional 2,212 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Doximity were worth $1,018,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Global Retirement Partners LLC increased its stake in Doximity by 468.1% in the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock valued at $29,000 after buying an additional 440 shares during the period. UMB Bank n.a. increased its stake in Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after buying an additional 235 shares during the period. Farther Finance Advisors LLC increased its stake in Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after buying an additional 603 shares during the period. Morse Asset Management Inc acquired a new position in Doximity in the 3rd quarter valued at $46,000. Finally, IFP Advisors Inc increased its stake in Doximity by 344.1% in the 4th quarter. IFP Advisors Inc now owns 1,328 shares of the company’s stock valued at $71,000 after buying an additional 1,029 shares during the period. 87.19% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have commented on DOCS shares. Leerink Partnrs upgraded shares of Doximity from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 7th. Truist Financial boosted their target price on shares of Doximity from $35.00 to $49.00 and gave the stock a “hold” rating in a research report on Thursday, November 14th. The Goldman Sachs Group boosted their target price on shares of Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Needham & Company LLC boosted their target price on shares of Doximity from $65.00 to $82.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Finally, Mizuho boosted their target price on shares of Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Eleven research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $64.22.

Doximity Trading Down 1.0 %

NASDAQ:DOCS opened at $67.78 on Wednesday. The firm has a market cap of $12.65 billion, a price-to-earnings ratio of 67.78, a price-to-earnings-growth ratio of 4.10 and a beta of 1.39. The company’s 50-day moving average is $62.30 and its two-hundred day moving average is $51.18. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21.

Insider Buying and Selling at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the transaction, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. This represents a 75.87 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 37.40% of the stock is owned by insiders.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.